DIGE enables the detection of a putative serum biomarker of fungal origin in a mouse model of invasive aspergillosis

Journal of Proteomics

Volumn 75, Issue 9, 2012, Pages 2536-2549

  Fekkar, A ^a,b,c   Pionneau, C ^b   Brossas, J Y ^a   Marinach Patrice, C ^a   Snounou, G ^a   Brock, M ^d   Ibrahim Granet, O ^e   Mazier, D ^a,b,c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d HANS KNÖLL INSTITUTE   (Germany)

^e INSTITUT PASTEUR   (France)

Author keywords

Aspergillus fumigatus; Biomarker; Diagnosis; DIGE; Host responses; Proteomic

Indexed keywords

BIOLOGICAL MARKER; FUNGAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; IN VIVO STUDY; LUNG ASPERGILLOSIS; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

ALLERGENS; ANIMALS; ANTIGENS, FUNGAL; ASPERGILLUS FUMIGATUS; BRONCHOALVEOLAR LAVAGE FLUID; FUNGAL PROTEINS; IMMUNOCOMPROMISED HOST; INVASIVE PULMONARY ASPERGILLOSIS; LUMINESCENT MEASUREMENTS; MICE; PRINCIPAL COMPONENT ANALYSIS; PROTEOMICS; SERUM AMYLOID A PROTEIN; SERUM AMYLOID P-COMPONENT; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

ASPERGILLUS FUMIGATUS; MUS;

EID: 84860458769     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.01.040     Document Type: Article

References (31)

1. Walsh T.J., Anaissie E.J., Denning D.W., Herbrecht R., Kontoyiannis D.P., Marr K.A., et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008, 46:327-360.
2. Kurup V.P., Kumar A. Immunodiagnosis of aspergillosis. Clin Microbiol Rev 1991, 4:439-456.
3. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
4. Pfeiffer C.D., Fine J.P., Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006, 42:1417-1427.
5. Petraitiene R., Petraitis V., Groll A.H., Sein T., Schaufele R.L., Francesconi A., et al. Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia. Antimicrob Agents Chemother 2002, 46:12-23.
6. Brock M., Jouvion G., Droin-Bergere S., Dussurget O., Nicola M.A., Ibrahim-Granet O. Bioluminescent Aspergillus fumigatus, a new tool for drug efficiency testing and in vivo monitoring of invasive aspergillosis. Appl Environ Microbiol 2008, 74:7023-7035.
7. Ibrahim-Granet O., Jouvion G., Hohl T.M., Droin-Bergere S., Philippart F., Kim O.Y., et al. In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosis. BMC Microbiol 2010, 10:105.
8. Anderson N.L., Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1:845-867.
9. Vasudev N.S., Ferguson R.E., Cairns D.A., Stanley A.J., Selby P.J., Banks R.E. Serum biomarker discovery in renal cancer using 2-DE and prefractionation by immunodepletion and isoelectric focusing; increasing coverage or more of the same?. Proteomics 2008, 8:5074-5085.
10. Sihlbom C., Kanmert I., Bahr H., Davidsson P. Evaluation of the combination of bead technology with SELDI-TOF-MS and 2-D DIGE for detection of plasma proteins. J Proteome Res 2008, 7:4191-4198.
11. Boschetti E., Giorgio Righetti P. Hexapeptide combinatorial ligand libraries: the march for the detection of the low-abundance proteome continues. Biotechniques 2008, 44:663-665.
12. Righetti P.G., Boschetti E., Lomas L., Citterio A. Protein Equalizer Technology : the quest for a "democratic proteome". Proteomics 2006, 6:3980-3992.
13. Fleck C.B., Brock M. Aspergillus fumigatus catalytic glucokinase and hexokinase: expression analysis and importance for germination, growth, and conidiation. Eukaryot Cell 2010, 9:1120-1135.
14. Banerjee B., Greenberger P.A., Fink J.N., Kurup V.P. Immunological characterization of Asp f 2, a major allergen from Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis. Infect Immun 1998, 66:5175-5182.
15. Banerjee B., Kurup V.P., Phadnis S., Greenberger P.A., Fink J.N. Molecular cloning and expression of a recombinant Aspergillus fumigatus protein Asp f II with significant immunoglobulin E reactivity in allergic bronchopulmonary aspergillosis. J Lab Clin Med 1996, 127:253-262.
16. Keidel E.M., Ribitsch D., Lottspeich F. Equalizer technology-Equal rights for disparate beads. Proteomics 2010, 10:2089-2098.
17. Agranoff D., Fernandez-Reyes D., Papadopoulos M.C., Rojas S.A., Herbster M., Loosemore A., et al. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 2006, 368:1012-1021.
18. Ngure R.M., Eckersall P.D., Jennings F.W., Mburu J., Burke J., Mungatana N., et al. Acute phase response in mice experimentally infected with Trypanosoma congolense: a molecular gauge of parasite-host interaction. Vet Parasitol 2008, 151:14-20.
19. Albuquerque L.M., Trugilho M.R., Chapeaurouge A., Jurgilas P.B., Bozza P.T., Bozza F.A., et al. Two-dimensional difference gel electrophoresis (DiGE) analysis of plasmas from dengue fever patients. J Proteome Res 2009, 8:5431-5441.
20. Thayan R., Huat T.L., See L.L., Tan C.P., Khairullah N.S., Yusof R., et al. The use of two-dimension electrophoresis to identify serum biomarkers from patients with dengue haemorrhagic fever. Trans R Soc Trop Med Hyg 2009, 103:413-419.
21. Gonzales D.A., De Torre C., Wang H., Devor C.B., Munson P.J., Ying S.X., et al. Protein expression profiles distinguish between experimental invasive pulmonary aspergillosis and Pseudomonas pneumonia. Proteomics 2010, 10:4270-4280.
22. de Torre C., Ying S.X., Munson P.J., Meduri G.U., Suffredini A.F. Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage. Proteomics 2006, 6:3949-3957.
23. Garlanda C., Hirsch E., Bozza S., Salustri A., De Acetis M., Nota R., et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002, 420:182-186.
24. Kramer H.B., Lavender K.J., Qin L., Stacey A.R., Liu M.K., di Gleria K., et al. Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection. PLoS Pathog 2010, 6:e1000893.
25. Kozel T.R., Wilson M.A., Farrell T.P., Levitz S.M. Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae. Infect Immun 1989, 57:3412-3417.
26. Sturtevant J.E., Latge J.P. Interactions between conidia of Aspergillus fumigatus and human complement component C3. Infect Immun 1992, 60:1913-1918.
27. Behnsen J., Lessing F., Schindler S., Wartenberg D., Jacobsen I.D., Thoen M., et al. Secreted Aspergillus fumigatus protease Alp1 degrades human complement proteins C3, C4, and C5. Infect Immun 2010, 78:3585-3594.
28. Rambach G., Dum D., Mohsenipour I., Hagleitner M., Wurzner R., Lass-Florl C., et al. Secretion of a fungal protease represents a complement evasion mechanism in cerebral aspergillosis. Mol Immunol 2010, 47:1438-1449.
29. Bolger M.S., Ross D.S., Jiang H., Frank M.M, Ghio A.J., Schwartz D.A., et al. Complement levels and activity in the normal and LPS-injured lung. Am J Physiol Lung Cell Mol Physiol 2007, 292:L748-L759.
30. Gordon-Thomson C., Kumari A., Tomkins L., Holford P, Djordjevic J.T., Wright L.C., et al. Chitotriosidase and gene therapy for fungal infections. Cell Mol Life Sci 2009, 66:1116-1125.
31. Chen L., Shen Z., Wu J. Expression, purification and in vitro antifungal activity of acidic mammalian chitinase against Candida albicans, Aspergillus fumigatus and Trichophyton rubrum strains. Clin Exp Dermatol 2009, 34:55-60.